Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

0Q6H

Hofseth Biocare Asa (0Q6H)

Hofseth Biocare Asa
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0Q6H
DateHeureSourceTitreSymboleSociété
16/05/202408h00UK RegulatoryHofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
10/05/202414h30UK RegulatoryHofseth Biocare ASA: Annual General Meeting completedLSE:0Q6HHofseth Biocare Asa
19/04/202413h00UK RegulatoryHofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024LSE:0Q6HHofseth Biocare Asa
19/04/202408h00UK RegulatoryHofseth Biocare ASA: HBC ANNUAL REPORT 2023LSE:0Q6HHofseth Biocare Asa
05/04/202418h08UK RegulatoryHofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDINGLSE:0Q6HHofseth Biocare Asa
21/03/202410h40UK RegulatoryHofseth Biocare ASA: UPDATED COMPANY PRESENTATIONLSE:0Q6HHofseth Biocare Asa
14/03/202412h12UK RegulatoryHofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWNLSE:0Q6HHofseth Biocare Asa
09/02/202408h00UK RegulatoryHofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
06/02/202415h56UK RegulatoryHofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activityLSE:0Q6HHofseth Biocare Asa
 Showing the most relevant articles for your search:LSE:0Q6H

Dernières Valeurs Consultées

Delayed Upgrade Clock